Summit Therapeutics (SMMT) had the highest return last quarter by a large-cap US stock, returning 179.3%.
| ASSET | QUARTER | % RETURN |
|---|---|---|
Summit Therapeutics (SMMT) | Q3 2024 | 179.34% |
Aurora Innovation (AUR) | Q3 2024 | 114.49% |
Rocket Lab USA (RKLB) | Q3 2024 | 103.56% |
Xpeng (XPEV) | Q3 2024 | 63.27% |
BeiGene (BGNE) | Q3 2024 | 55.59% |
JD Inc Adr (JD) | Q3 2024 | 54.26% |
Nio Inc Class A ADR (NIO) | Q3 2024 | 53.56% |
Applovin (APP) | Q3 2024 | 53.37% |
Ubiquiti Networks (UI) | Q3 2024 | 52.33% |
Vaxcyte (PCVX) | Q3 2024 | 51.49% |
GE Vernova LLC (GEV) | Q3 2024 | 49.11% |
Erie Indemnity (ERIE) | Q3 2024 | 48.73% |
BioNTech SE (BNTX) | Q3 2024 | 48.06% |
Alibaba (BABA) | Q3 2024 | 46.35% |
Palantir Technologies (PLTR) | Q3 2024 | 46% |
Futu (FUTU) | Q3 2024 | 44.97% |
Yum China (YUMC) | Q3 2024 | 44.52% |
SharkNinja (SN) | Q3 2024 | 44.31% |
Samsara (IOT) | Q3 2024 | 43.21% |
Liberty Broadband Srs C (LBRDK) | Q3 2024 | 42.52% |
Liberty Broadband Srs A (LBRDA) | Q3 2024 | 41.58% |
TransUnion (TRU) | Q3 2024 | 41.13% |
Kellanova (K) | Q3 2024 | 40.64% |
CBRE Group Inc Class A (CBRE) | Q3 2024 | 40.23% |
Rocket Companies (RKT) | Q3 2024 | 39.77% |
Large-cap stocks are treated as having a market cap of $10B+.
